DOI:
10.1055/s-00035037
Methods of Information in Medicine
LinksClose Window
References
Barst RJ, Langleben D, Badesch D. et al.
STRIDE-2 Study Group. Treatment of pulmonary arterial hypertension with the selective endothelin-a receptor antagonist sitaxsentan.
J Am Coll Cardiol 2006;
47 (10) 2049-2056
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.